Innate immunity in triggering and resolution of acute gouty inflammation

Current Rheumatology Reports

Volumn 8, Issue 3, 2006, Pages 209-214

  Rose, David M ^b   Liu Bryan, Ru ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; TOLL LIKE RECEPTOR; URATE;

APOPTOSIS; ARTICLE; CELL ACTIVATION; GOUT; HUMAN; INFLAMMATION; INNATE IMMUNITY; REMISSION; ACUTE DISEASE; IMMUNOLOGY; RECURRENT DISEASE; REVIEW;

ACUTE DISEASE; GOUT; HUMANS; IMMUNITY, NATURAL; RECURRENCE; REMISSION, SPONTANEOUS;

EID: 33747607927     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-996-0027-1     Document Type: Article

References (49)

1. Terkeltaub R: Pathogenesis and treatment of crystal-induced inflammation. In: Arthritis and allied conditions, edn. 15. Edited by Koopman W. Philadelphia: Lippincott Williams and Wilkins; 2004:2357-2365.
2. Landis RC, Haskard DO: Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 2001, 3:36-41.
3. Nishimura A, Akahoshi T, Takahashi M, et al.: Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997, 62:444-449.
4. Terkeltaub R, Baird S, Searas P, et al.: The murine homolog of the interleukin-8 receptor CXCR2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998, 41:900-909.
5. Ryckman C, Gilbert C, De Medicis R, et al.: Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol 2004, 76:433-440.
6. Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH: Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis. Arthritis Rheum 1983, 26:775-783.
7. Terkeltaub R, Smeltzer D, Curtiss LK, Ginsberg MH: Low density lipoprotein inhibits the physical interaction of phlogistic crystals and inflammatory cells. Arthritis Rheum 1986, 29:363-370.
8. Abramson S, Hoffstein ST, Weissmann G: Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum 1982, 25:174-180.
9. Barabe F, Gillbert C, Liao N, et al.: Crystal-induced neutrophil activation.VI. Involvement of Fc gamma RIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J 1998, 12:209-220.
10. Liu-Bryan R, Liote F: Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint Bone Spine 2005, 72:295-302.
11. Pouliot M, James MJ, McColl SR, et al.: Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998, 91:1769-1776.
12. Fujiwara K, Ohkawara S, Takagi K, et al.: Involvement of CXC chemokine growth-related oncogene-alpha in monosodium urate crystal-induced arthritis in rabbits. Lab Invest 2002, 82:1297-1304.
13. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
14. Fields TR, Abramson SB, Weissmann G, et al.: Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol 1983; 26:249-257.
15. Russell IJ, Mansen C, Kolb LM, et al.: Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol 1982, 24:239-250.
16. Tramontini N, Huber C, Liu-Bryan R, et al.: Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum 2004, 50:2633-2639.
17. Liu-Bryan R, Pritzker K, Firestein GS, et al.: TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosdium urate crystal-induced nitric oxide generation. J Immunol 2005, 174:5016-5023.
18. Liu-Bryan R, Scott P, Sydlaske A, et al.: Innate immunity conferred by TLR2, TLR4 and MyD88 expression is pivotal for monosodium urate crystal-induced inflammation. Arthritis Rheum 2005, 52:2936-2946. This is the first study demonstrated that pattern recognition receptors TLR2, TLR4 and their adaptor protein MyD88 mediates bone marrow derived macrophages to phaocytose MSU crystals and induce cytokine expression in vitro, and inflammatory responses to MSU crystals in vivo.
19. Iwaki D, Mitsuzawa H, Murakami S, et al.: The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J Biol Chem 2002, 277:24315-24320.
20. Fujihara M, Muroi M, Tanamoto K, et al.: Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 2003, 100:171-194.
21. Scott P, Terkeltaub RA, Bryan RL: The shared extracellular TLR2 and TLR4 adaptor molecule CD14 is required for acute monosodium urate crystal-induced inflammation in vivo. Arthritis Rheum 2005, 52(Suppl):S270.
22. Sendide K, Reiner NE, Lee JS, et al.: Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 2005, 174:4210-4219.
23. Athanasou NA, Quinn J: Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow derived cells. Ann Rheum Dis 1991, 50:311-315.
24. Radstake TR, Roelofs MF, Jenniskens YM, et al.: Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 2004, 50:3856-3865.
25. Parker LC, Whyte MK, Dower SK, Sabroe I: The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 2005, 77:886-892.
26. Weingarten R, Sklar LA, Mathison JC, et al.: Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol 1993, 53:518-524.
27. Schumacher HR: Pathology of the synovial membrane in gout. Light and electron microscopic studies. Interpretation of crystals in electron micrographs. Arthritis Rheum 1975, 18(Suppl 6):771-782.
28. Martinon F, Petrilli V, Mayor A, et al.: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, In press. This paper demonstrated that MSU crystals engage NALP3/cryopyrin, a potential intracellular pattern recognition receptor, to activate inflammasome that mediates caspase-1 activation and subsequent processing of IL-1β and IL-18.
29. Martinon F, Tschopp J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005, 26:447-454.
30. Martinon F, Agostini L, Meylan E, Tschopp J: Identification of bacterial muramyl dipeptide as activator of the NALP3/ cryopyrin inflammasome. Curr Biol 2004, 14:1929-1934.
31. Pascual E, Jovani V: A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asympotmatic joints of patients with gout. Br J Rheumatol 1995, 34:724-726.
32. Yagnik DR, Hillyer P, Marshall D, et al.: Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000, 43:1779-1789.
33. Landis RC, Yagnik DR, Florey O, et al.: Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated marcrophages. Arthritis Rheum 2002, 46:3026-3033. The work demonstrates that the state of monocyte/macrophage differentiation impacts the cellular response to MSU crystals. It was found that MSU crystals trigger a proinflammatory phenotype in less differentiated macrophages, while MSU crystals trigger a non-inflammatory phenotype in more mature macrophages.
34. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
35. Ortiz-Bravo E, Sieck MS, Schumacher HR Jr: Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993, 36:1274-1285.
36. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK: Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neturophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991, 87:20-26.
37. Savill J, Dransfield I, Gregory C, Haslett C: A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002, 2:965-975.
38. Manderson AP, Botta M, Walport MJ: The role of comoplement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004, 22:431-456.
39. Fadok VA, Bratton DL, Konowal A, et al.: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
40. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002, 109:41-50.
41. Yagnik DR, Evans BJ, Florey O, et al.: Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004, 50:2273-2280.
42. Liote F, Prudhommeaux F, Schiltz C, et al.: Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor betal. Arthritis Rheum 1996, 39:1192-1198.
43. Murakami Y, Akahoshi T, Kawai S, et al.: Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum 2002, 46:2504-2513.
44. Murakami Y, Akahoshi T, Hayashi I, et al.: Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Arthritis Rheum 2003, 48:2931-2941.
45. Akahoshi T, Namai R, Murakami Y, et al.: Rapid induction of peroxisome proliferator-activated receptor g expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 2003, 48:231-239.
46. Ward C, Dransfield I, Murray J, et al.: Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol 2002, 168:6232-6243.
47. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197.
48. Ogawa S, Lozach J, Benner C, et al.: Molecular determinants of rosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721.
49. Liu Y, Cousin JM, Hughes J, et al.: Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999, 162:3639-3646.